These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 30633331)
1. The effects of a randomized trial of brief forms of stress management on RAGE-associated S100A8/A9 in patients with breast cancer undergoing primary treatment. Taub CJ; Lippman ME; Hudson BI; Blomberg BB; Diaz A; Fisher HM; Nahin ER; Lechner SC; Kwak T; Hwang GH; Antoni MH Cancer; 2019 May; 125(10):1717-1725. PubMed ID: 30633331 [TBL] [Abstract][Full Text] [Related]
2. Effects of brief stress management interventions on distress and leukocyte nuclear factor kappa B expression during primary treatment for breast cancer: A randomized trial. Diaz A; Taub CJ; Lippman ME; Antoni MH; Blomberg BB Psychoneuroendocrinology; 2021 Apr; 126():105163. PubMed ID: 33611132 [TBL] [Abstract][Full Text] [Related]
3. Relationships Between Serum Cortisol, RAGE-Associated s100A8/A9 Levels, and Self-Reported Cancer-Related Distress in Women With Nonmetastatic Breast Cancer. Taub CJ; Diaz A; Blomberg BB; Jutagir DR; Fisher HM; Gudenkauf LM; Lippman ME; Hudson BI; Antoni MH Psychosom Med; 2022 Sep; 84(7):803-807. PubMed ID: 35980780 [TBL] [Abstract][Full Text] [Related]
4. RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition. Yin C; Li H; Zhang B; Liu Y; Lu G; Lu S; Sun L; Qi Y; Li X; Chen W Breast Cancer Res Treat; 2013 Nov; 142(2):297-309. PubMed ID: 24177755 [TBL] [Abstract][Full Text] [Related]
5. S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling. Volz HC; Laohachewin D; Seidel C; Lasitschka F; Keilbach K; Wienbrandt AR; Andrassy J; Bierhaus A; Kaya Z; Katus HA; Andrassy M Basic Res Cardiol; 2012 Mar; 107(2):250. PubMed ID: 22318783 [TBL] [Abstract][Full Text] [Related]
6. Differential release and deposition of S100A8/A9 proteins in inflamed upper airway tissue. Van Crombruggen K; Vogl T; Pérez-Novo C; Holtappels G; Bachert C Eur Respir J; 2016 Jan; 47(1):264-74. PubMed ID: 26493794 [TBL] [Abstract][Full Text] [Related]
7. Proinflammatory effects of S100A8/A9 via TLR4 and RAGE signaling pathways in BV-2 microglial cells. Ma L; Sun P; Zhang JC; Zhang Q; Yao SL Int J Mol Med; 2017 Jul; 40(1):31-38. PubMed ID: 28498464 [TBL] [Abstract][Full Text] [Related]
8. Brief cognitive-behavioral and relaxation training interventions for breast cancer: A randomized controlled trial. Gudenkauf LM; Antoni MH; Stagl JM; Lechner SC; Jutagir DR; Bouchard LC; Blomberg BB; Glück S; Derhagopian RP; Giron GL; Avisar E; Torres-Salichs MA; Carver CS J Consult Clin Psychol; 2015 Aug; 83(4):677-688. PubMed ID: 25939017 [TBL] [Abstract][Full Text] [Related]
9. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis. Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236 [TBL] [Abstract][Full Text] [Related]
10. Colon-targeted S100A8/A9-specific peptide systems ameliorate colitis and colitis-associated colorectal cancer in mouse models. Cho E; Mun SJ; Kim HK; Ham YS; Gil WJ; Yang CS Acta Pharmacol Sin; 2024 Mar; 45(3):581-593. PubMed ID: 38040838 [TBL] [Abstract][Full Text] [Related]
11. S100A8/A9: From basic science to clinical application. Pruenster M; Vogl T; Roth J; Sperandio M Pharmacol Ther; 2016 Nov; 167():120-131. PubMed ID: 27492899 [TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products increase expression of S100A8 and A9 via RAGE-MAPK in rat dental pulp cells. Nakajima Y; Inagaki Y; Kido J; Nagata T Oral Dis; 2015 Apr; 21(3):328-34. PubMed ID: 25098709 [TBL] [Abstract][Full Text] [Related]
13. S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2. Ghavami S; Kerkhoff C; Chazin WJ; Kadkhoda K; Xiao W; Zuse A; Hashemi M; Eshraghi M; Schulze-Osthoff K; Klonisch T; Los M Biochim Biophys Acta; 2008 Feb; 1783(2):297-311. PubMed ID: 18060880 [TBL] [Abstract][Full Text] [Related]
14. S100A8/A9 stimulates keratinocyte proliferation in the development of squamous cell carcinoma of the skin via the receptor for advanced glycation-end products. Iotzova-Weiss G; Dziunycz PJ; Freiberger SN; Läuchli S; Hafner J; Vogl T; French LE; Hofbauer GF PLoS One; 2015; 10(3):e0120971. PubMed ID: 25811984 [TBL] [Abstract][Full Text] [Related]
15. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding. Ruma IM; Putranto EW; Kondo E; Murata H; Watanabe M; Huang P; Kinoshita R; Futami J; Inoue Y; Yamauchi A; Sumardika IW; Youyi C; Yamamoto K; Nasu Y; Nishibori M; Hibino T; Sakaguchi M Clin Exp Metastasis; 2016 Aug; 33(6):609-27. PubMed ID: 27151304 [TBL] [Abstract][Full Text] [Related]
16. Functional characterization of S100A8 and S100A9 in altering monolayer permeability of human umbilical endothelial cells. Wang L; Luo H; Chen X; Jiang Y; Huang Q PLoS One; 2014; 9(3):e90472. PubMed ID: 24595267 [TBL] [Abstract][Full Text] [Related]
17. RAGE-dependent regulation of calcium-binding proteins S100A8 and S100A9 in human THP-1. Eggers K; Sikora K; Lorenz M; Taubert T; Moobed M; Baumann G; Stangl K; Stangl V Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):353-7. PubMed ID: 21472666 [TBL] [Abstract][Full Text] [Related]
18. Association Between Clinicopathological Parameters and S100A8/A9 Expression According to Smoking History in Patients With Non-small Cell Lung Cancer. Cho SB; Kim IK; Yeo CD; Lee SH In Vivo; 2024; 38(1):474-481. PubMed ID: 38148054 [TBL] [Abstract][Full Text] [Related]
19. S100A8/A9 promotes parenchymal damage and renal fibrosis in obstructive nephropathy. Tammaro A; Florquin S; Brok M; Claessen N; Butter LM; Teske GJD; de Boer OJ; Vogl T; Leemans JC; Dessing MC Clin Exp Immunol; 2018 Sep; 193(3):361-375. PubMed ID: 29746703 [TBL] [Abstract][Full Text] [Related]
20. S100A8/A9 activate key genes and pathways in colon tumor progression. Ichikawa M; Williams R; Wang L; Vogl T; Srikrishna G Mol Cancer Res; 2011 Feb; 9(2):133-48. PubMed ID: 21228116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]